Thrombocytes are effectors of the innate immune system releasing human beta defensin-3

Mersedeh Tohidnezhad1, Deike Varoga, Rainer Podschun

  • 1Department of Anatomy and Cell Biology, RWTH Aachen University, Germany. mtohidnezhad@ukaachen.de

Injury
|February 12, 2011
PubMed
Abstract

Insights

Platelet-rich plasma (PRP) exhibits antimicrobial properties against gram-positive and gram-negative bacteria. This study identified human beta defensin-3 (HBD-3) as a key component responsible for PRP's antibacterial action, supporting its use in surgery.

Area of Science:

  • Orthopaedic Surgery
  • Microbiology
  • Biochemistry

Background:

  • Platelet-rich plasma (PRP) is widely used in surgery to enhance healing.
  • Emerging evidence suggests PRP possesses antimicrobial properties.
  • This study focused on PRP's efficacy against gram-negative bacteria common in orthopedic trauma.

Purpose of the Study:

  • To investigate the antimicrobial effects of platelet-rich plasma (PRP).
  • To assess PRP's activity against clinically relevant gram-negative pathogens.
  • To identify potential antimicrobial components within PRP.

Main Methods:

  • PRP was prepared from liquid preserved thrombocyte concentrates.
  • ELISA, Western blot, and immunohistochemistry were used to analyze PRP composition.
  • Radial diffusion assays assessed PRP's antimicrobial activity against various bacteria.

Main Results:

  • Human beta defensin-3 (HBD-3) was detected in bactericidal concentrations in PRP.
  • PRP demonstrated effective inhibition against Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
  • Antimicrobial activity was also observed against Bacterium megaterium and Enterococcus faecalis.

Conclusions:

  • PRP exhibits significant antimicrobial action against both gram-positive and gram-negative bacteria.
  • The secretion of HBD-3 is identified as a primary mechanism for PRP's antibacterial effect.
  • These findings broaden the potential clinical applications of autologous PRP preparations in surgery.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...